Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP697170.RAp265bJB2a9Z6sLWmA1CLKamAU_YTZS4wAub9tJikM4E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP697170.RAp265bJB2a9Z6sLWmA1CLKamAU_YTZS4wAub9tJikM4E130_assertion type Assertion NP697170.RAp265bJB2a9Z6sLWmA1CLKamAU_YTZS4wAub9tJikM4E130_head.
- NP697170.RAp265bJB2a9Z6sLWmA1CLKamAU_YTZS4wAub9tJikM4E130_assertion description "[Thus, GALN amplification is unlikely to contribute to the phenotype conferred by 11q13 amplification in breast cancer, but preprogalanin mRNA is expressed by breast cancer cells and is under steroid hormone control in estrogen receptor-positive cells, opening the wider question of the role of this steroid-regulated neuropeptide in the normal and cancerous breast.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697170.RAp265bJB2a9Z6sLWmA1CLKamAU_YTZS4wAub9tJikM4E130_provenance.
- NP697170.RAp265bJB2a9Z6sLWmA1CLKamAU_YTZS4wAub9tJikM4E130_assertion evidence source_evidence_literature NP697170.RAp265bJB2a9Z6sLWmA1CLKamAU_YTZS4wAub9tJikM4E130_provenance.
- NP697170.RAp265bJB2a9Z6sLWmA1CLKamAU_YTZS4wAub9tJikM4E130_assertion SIO_000772 9537228 NP697170.RAp265bJB2a9Z6sLWmA1CLKamAU_YTZS4wAub9tJikM4E130_provenance.
- NP697170.RAp265bJB2a9Z6sLWmA1CLKamAU_YTZS4wAub9tJikM4E130_assertion wasDerivedFrom befree-20140225 NP697170.RAp265bJB2a9Z6sLWmA1CLKamAU_YTZS4wAub9tJikM4E130_provenance.
- NP697170.RAp265bJB2a9Z6sLWmA1CLKamAU_YTZS4wAub9tJikM4E130_assertion wasGeneratedBy ECO_0000203 NP697170.RAp265bJB2a9Z6sLWmA1CLKamAU_YTZS4wAub9tJikM4E130_provenance.